| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.81B | +2.2% |
| Cost of Revenue | $774.6M | -6.5% |
| Gross Profit | $2.03B | +5.9% |
| R&D Expense | $443.1M | -5.6% |
| SG&A Expense | $353.9M | +3.1% |
| Operating Income | $380.2M | +35.9% |
| Pre-tax Income | $410.8M | +40.3% |
| Income Tax | $107.5M | +828.9% |
| Net Income | $303.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $811.2M | -11.3% |
| Accounts Receivable | $8.7M | -64.8% |
| Current Assets | $1.33B | -15.5% |
| Total Assets | $2.42B | -10.0% |
| Current Liabilities | $665.1M | -6.4% |
| Long-term Debt | $2.29B | +0.2% |
| Total Liabilities | $3.18B | -1.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $752.5M | +6.7% |
| Capital Expenditures | $14.2M | +9.8% |
| Investing Cash Flow | -$53.1M | +27.6% |
| Financing Cash Flow | -$787.2M | -19.9% |
| Free Cash Flow | $738.3M | +6.6% |
| -1.4% |
| EPS (Basic) | $2.64 | +5.2% |
| EPS (Diluted) | $2.35 | +4.9% |
| Stockholders' Equity |
| -$758.9M |
| -39.6% |